Emergence of Vertebrate Retroviruses and Envelope Capture
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: a Review
viruses Review Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review Dong Joo Seo 1 and Changsun Choi 2,* 1 Department of Food Science and Nutrition, College of Health and Welfare and Education, Gwangju University 277 Hyodeok-ro, Nam-gu, Gwangju 61743, Korea; [email protected] 2 Department of Food and Nutrition, School of Food Science and Technology, College of Biotechnology and Natural Resources, Chung-Ang University, 4726 Seodongdaero, Daeduck-myun, Anseong-si, Gyeonggi-do 17546, Korea * Correspondence: [email protected]; Tel.: +82-31-670-4589; Fax: +82-31-676-8741 Abstract: Mushrooms are used in their natural form as a food supplement and food additive. In addition, several bioactive compounds beneficial for human health have been derived from mushrooms. Among them, polysaccharides, carbohydrate-binding protein, peptides, proteins, enzymes, polyphenols, triterpenes, triterpenoids, and several other compounds exert antiviral activity against DNA and RNA viruses. Their antiviral targets were mostly virus entry, viral genome replication, viral proteins, and cellular proteins and influenced immune modulation, which was evaluated through pre-, simultaneous-, co-, and post-treatment in vitro and in vivo studies. In particular, they treated and relieved the viral diseases caused by herpes simplex virus, influenza virus, and human immunodeficiency virus (HIV). Some mushroom compounds that act against HIV, influenza A virus, and hepatitis C virus showed antiviral effects comparable to those of antiviral drugs. Therefore, bioactive compounds from mushrooms could be candidates for treating viral infections. Citation: Seo, D.J.; Choi, C. Antiviral Bioactive Compounds of Mushrooms Keywords: mushroom; bioactive compound; virus; infection; antiviral mechanism and Their Antiviral Mechanisms: A Review. -
Characterization of the Matrix Proteins of the Fish Rhabdovirus, Infectious Hematopoietic Necrosis Virus
AN ABSTRACT OF THE THESIS OF Patricia A. Ormonde for the degree of Master of Science presented on April 14. 1995. Title: Characterization of the Matrix Proteins of the Fish Rhabdovinis, Infectious Hematopoietic Necrosis Virus. Redacted for Privacy Abstract approved: Jo-Ann C. ong Infectious hematopoietic necrosis virus (1HNV) is an important fish pathogen enzootic in salmon and trout populations of the Pacific Northwestern United States. Occasional epizootics in fish hatcheries can result in devastating losses of fish stocks. The complete nucleotide sequence of IHNV has not yet been determined. This knowledge is the first step towards understanding the roles viral proteins play in IHNV infection, and is necessary for determining the relatedness of IHNV to other rhabdoviruses. The glycoprotein, nucleocapsid and non-virion genes of IHNV have been described previously; however, at the initiation of this study, very little was known about the matrix protein genes. Rhabdoviral matrix proteins have been found to be important in viral transcription and virion assembly. This thesis describes the preliminary characterization of the M1 and M2 matrix proteins of IHNV. In addition, the trout humoral immune response to M1 and M2 proteins expressed from plasmid DNA injected into the fish was investigated. This work may prove useful in designing future vaccines against IHN. The sequences of M1 phosphoprotein and M2 matrix protein genes of IHNV were determined from both genomic and mRNA clones. Analysis of the sequences indicated that the predicted open reading frame of M1 gene encoded a 230 amino acid protein with a estimated molecular weight of 25.6 kDa. Further analysis revealed a second open reading frame encoding a 42 amino acid protein with a calculated molecular weight of 4.8 kDa. -
Detection of Respiratory Viruses and Subtype Identification of Inffuenza a Viruses by Greenechipresp Oligonucleotide Microarray
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2007, p. 2359–2364 Vol. 45, No. 8 0095-1137/07/$08.00ϩ0 doi:10.1128/JCM.00737-07 Copyright © 2007, American Society for Microbiology. All Rights Reserved. Detection of Respiratory Viruses and Subtype Identification of Influenza A Viruses by GreeneChipResp Oligonucleotide Microarrayᰔ† Phenix-Lan Quan,1‡ Gustavo Palacios,1‡ Omar J. Jabado,1 Sean Conlan,1 David L. Hirschberg,2 Francisco Pozo,3 Philippa J. M. Jack,4 Daniel Cisterna,5 Neil Renwick,1 Jeffrey Hui,1 Andrew Drysdale,1 Rachel Amos-Ritchie,4 Elsa Baumeister,5 Vilma Savy,5 Kelly M. Lager,6 Ju¨rgen A. Richt,6 David B. Boyle,4 Adolfo Garcı´a-Sastre,7 Inmaculada Casas,3 Pilar Perez-Bren˜a,3 Thomas Briese,1 and W. Ian Lipkin1* Jerome L. and Dawn Greene Infectious Disease Laboratory, Mailman School of Public Health, Columbia University, New York, New York1; Stanford School of Medicine, Palo Alto, California2; Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain3; CSIRO Livestock Industries, Australian Animal Health Laboratory, Victoria, Australia4; Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos G. Malbra´n, Buenos Aires, Argentina5; National Animal Disease Center, USDA, Ames, Iowa6; and Department of Microbiology and Emerging Pathogens Institute, 7 Mount Sinai School of Medicine, New York, New York Downloaded from Received 4 April 2007/Returned for modification 15 May 2007/Accepted 21 May 2007 Acute respiratory infections are significant causes of morbidity, mortality, and economic burden worldwide. An accurate, early differential diagnosis may alter individual clinical management as well as facilitate the recognition of outbreaks that have implications for public health. -
Parallels Among Positive-Strand RNA Viruses, Reverse-Transcribing Viruses and Double-Stranded RNA Viruses
REVIEWS Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses Paul Ahlquist Abstract | Viruses are divided into seven classes on the basis of differing strategies for storing and replicating their genomes through RNA and/or DNA intermediates. Despite major differences among these classes, recent results reveal that the non-virion, intracellular RNA- replication complexes of some positive-strand RNA viruses share parallels with the structure, assembly and function of the replicative cores of extracellular virions of reverse-transcribing viruses and double-stranded RNA viruses. Therefore, at least four of seven principal virus classes share several underlying features in genome replication and might have emerged from common ancestors. This has implications for virus function, evolution and control. Positive-strand RNA virus Despite continuing advances, established and emerging ssRNA or dsRNA. Other viruses replicate by intercon- A virus, the infectious virions of viruses remain major causes of human disease, with verting their genomes between RNA and DNA. The viri- which contain the genome in a dramatic costs in mortality, morbidity and economic ons of such reverse-transcribing viruses always initially single-stranded, messenger- terms. In addition to acute diseases, viruses cause at package the RNA forms of their genomes, and either sense RNA form. least 15–20% of human cancers1,2 and are implicated in might (for example, hepadnaviruses and foamy retro- neurological and other chronic disorders. One of many viruses) or might not (for example, orthoretroviruses) challenges in controlling viruses and virus-mediated dis- reverse-transcribe the RNA into DNA before the virion eases is that viruses show an amazing diversity in basic exits the initially infected producer cell. -
Murine Models for Evaluating Antiretroviral Therapy1
[CANCER RESEARCH (SUPPL.) 50. 56l8s-5627s, September 1, I990| Murine Models for Evaluating Antiretroviral Therapy1 Ruth M. Ruprecht,2 Lisa D. Bernard, Ting-Chao Chou, Miguel A. Gama Sosa, Fatemeh Fazely, John Koch, Prem L. Sharma, and Steve Mullaney Division of Cancer Pharmacology. Dana-Farber Cancer Institute ¡R.M. R., L. D. B., M. A. G. S.. F. F.. J. K.. P. L. S., S. M.J; Departments of Medicine [R. M. K.J. Pathology ¡M.A. G. S.J, and Biological Chemistry and Molecular Pharmacology [F. F., J. K., P. L. S.J. Harvard Medical School, Boston, Massachusetts 02115, and Memorial Sloan-Kettering Cancer Center ¡T-C.C.], New York, New York 10021 Abstract Prior to using a given animal model system to test a candidate anti-AIDS agent, the following questions need to be addressed: The pandemic of the acquired immunodeficiency syndrome (AIDS), (a) Is the potential anti-AIDS drug an antiviral agent or an caused by the human immunodeficiency virus type 1 (IIIV-I ). requires immunomodulator that may be able to restore certain immune rapid development of effective therapy and prevention. Analysis of can didate anti-HIV-1 drugs in animals is problematic since no ideal animal functions? Thus, is a candidate anti-AIDS drug likely to be model for IIIV-I infection and disease exists. For many reasons, including active during the phase of asymptomatic viremia or only during small size, availability of inbred strains, immunological reagents, and overt disease? (¿>)Does a candidate antiviral agent inhibit a lymphokines, murine systems have been used for in vivo analysis of retroviral function shared by all retroviruses such as gag, pol, antiretroviral agents. -
Theory of an Immune System Retrovirus
Proc. Nati. Acad. Sci. USA Vol. 83, pp. 9159-9163, December 1986 Medical Sciences Theory of an immune system retrovirus (human immunodeficiency virus/acquired immune deficiency syndrome) LEON N COOPER Physics Department and Center for Neural Science, Brown University, Providence, RI 02912 Contributed by Leon N Cooper, July 23, 1986 ABSTRACT Human immunodeficiency virus (HIV; for- initiates clonal expansion, sustained by interleukin 2 and y merly known as human T-cell lymphotropic virus type interferon. Ill/lymphadenopathy-associated virus, HTLV-Ill/LAV), the I first give a brief sketch of these events in a linked- retrovirus that infects T4-positive (helper) T cells of the interaction model in which it is assumed that antigen-specific immune system, has been implicated as the agent responsible T cells must interact with the B-cell-processed virus to for the acquired immune deficiency syndrome. In this paper, initiate clonal expansion (2). I then assume that virus-specific I contrast the growth of a "normal" virus with what I call an antibody is the major component ofimmune system response immune system retrovirus: a retrovirus that attacks the T4- that limits virus spread. As will be seen, the details of these positive T cells of the immune system. I show that remarkable assumptions do not affect the qualitative features of my interactions with other infections as well as strong virus conclusions. concentration dependence are general properties of immune Linked-Interaction Model for Clonal Expansion of Lympho- system retroviruses. Some of the consequences of these ideas cytes. Let X be the concentration of normal infecting virus are compared with observations. -
Discovery of HTLV-1, the First Human Retrovirus, Its Unique Regulatory Mechanisms, and Insights Into Pathogenesis
Oncogene (2005) 24, 5931–5937 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis Mitsuaki Yoshida*,1 1Banyu Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., 3 Ohkubo, Tsukuba, Ibaraki 300-2611, Japan I briefly review the discovery and characterization of the In Japan something was there, but it was not clear first human retrovirus, human T-cell leukemia virus type 1, focusing on contributions from Japanese researchers. Discovery of ATL The unique regulatory mechanisms for the viral regulation The first key event for human retrovirus was the with Tax and Rex, etiology of ATL and possible discovery of adult T-cell leukemia (ATL) by Kiyoshi leukemogenic mechanism with Tax are also discussed Takatsuki and his colleagues in Japan in 1976 (Uchi- briefly. et al Oncogene (2005) 24, 5931–5937. doi:10.1038/sj.onc.1208981 yama ., 1977). The reports from his laboratory described unique characteristics of the leukemia such as Keywords: HTLV-1; transcription; tumor-suppressor unusual morphology of leukemic cells with lobulated genes; cell cycle; epidemiology nuclei and surface phenotypes. The most striking feature of the disease was the Kyushu (West part of Japan) origin of most of the patients who were identified in Kyoto where Takatsuki’s group performed their research. Takatsuki’s findings were later confirmed by extensive epidemiology and a clear clustering of Introduction ATL cases in the Kyushu area strongly suggested a unique etiology (Hinuma et al., 1981a). At the time, When virologists and oncologists are challenged to this novel discovery elicited enormous attention from identify human tumor viruses, they dream of the physicians, virologists, epidemiologists and oncologists, contribution of such viruses towards understanding but still there was no clue as to how to search for an cancers and answering questions such as how and why etiology. -
A Proposal for a New Approach to a Preventive Vaccine Against Human Immunodeficiency Virus Type 1 (Simpler Retrovirus/More Complex Retrovirus/Co-Virus) HOWARD M
Proc. Natl. Acad. Sci. USA Vol. 90, pp. 4419-4420, May 1993 Medical Sciences A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1 (simpler retrovirus/more complex retrovirus/co-virus) HOWARD M. TEMIN McArdle Laboratory, 1400 University Avenue, Madison, WI 53706 Contributed by Howard M. Temin, February 22, 1993 ABSTRACT Human immunodeficiency virus type 1 retroviruses infected our ancestors, as shown by the relic (HIV-1) is a more complex retrovirus, coding for several proviruses in human DNA (7-16). accessory proteins in addition to the structural proteins (Gag, More complex retroviruses were first isolated in horses Pol, and Env) that are found in all retroviruses. More complex (equine infectious anemia virus). Since then they have been retroviruses have not been isolated from birds, and simpler isolated from many other mammals, including at least five retroviruses have not been isolated from humans. However, the from humans (HIV-1, HIV-2, HTLV-I, HTLV-II, and proviruses of many endogenous simpler retroviruses are pres- HSRV). So far, more complex retroviruses have not been ent in the human genome. These observations suggest that isolated from vertebrate families other than mammals, and humans can mount a successful protective response against simpler retroviruses have not been isolated from humans or simpler retrovrwuses, whereas birds cannot. Thus, humans ungulates. However, more complex retroviruses have been might be able to mount a successful protective response to isolated from both humans and ungulates. infection with a simpler HIV-1. As a model, a simpler bovine I propose that this phylogenetic distribution is not an leukemia virus which is capable of replicating has been con- artifact of virus isolation techniques, but that it reflects the structed; a simpler HIV-1 could be constructed in a similar ability of humans and ungulates to respond to infection by fashion. -
SIVISV.BOOK Layout 1
SEDE Piattaforma FAD Nadirex http://nadirex.dnaconnect.sm ORGANIZING SECRETARIAT AND PROVIDER NR. 265 Nadirex International S.r.l. Via Riviera, 39 - 27100 Pavia Tel. +39.0382.525714 Fax. +39.0382.525736 Contact: Gloria Molla [email protected] mob. +39 347 8589333 Contact: Francesca Granata [email protected] www.nadirex.com www.congressosivsiv.com ORGANIZING COMMITTEE PRESIDENT Arnaldo Caruso (Brescia, Italy) CHAIRS Guido Antonelli (Rome, Italy) Franco Buonaguro (Naples, Italy) Arnaldo Caruso (Brescia, Italy) Massimiliano Galdiero (Naples, Italy) Giuseppe Portella (Naples, Italy) SCIENTIFIC SECRETARIAT Francesca Caccuri (Brescia, Italy) Rossana Cavallo (Turin, Italy) Massimo Clementi (Milan, Italy) Gianluigi Franci (Salerno, Italy) Maria Cristina Parolin (Padua, Italy) Alessandra Pierangeli (Rome, Italy) Luisa Rubino (Bari, Italy) Gabriele Vaccari (Rome, Italy) EXECUTIVE BOARD Guido Antonelli (Rome, Italy) Franco Buonaguro (Naples, Italy) Arnaldo Caruso (Brescia, Italy) Massimiliano Galdiero (Naples, Italy) Giuseppe Portella (Naples, Italy) 3 EXECUTIVE BOARD PRESIDENT Arnaldo Caruso (Brescia, Italy) VICE PRESIDENT Canio Buonavoglia, University of Bari (Bari, Italy) SECRETARY Giorgio Gribaudo, University of Turin (Turin, Italy) TREASURER Luisa Rubino, National Research Council (Bari, Italy) ADVISER Guido Antonelli, University of Rome “La Sapienza” (Rome, Italy) ADVISORY COUNCIL Elisabetta Affabris (Rome, Italy) Fausto Baldanti (Pavia, Italy) Lawrence Banks (Trieste, Italy) Roberto Burioni (Milan, Italy) Arianna Calistri -
RNA Viruses As Tools in Gene Therapy and Vaccine Development
G C A T T A C G G C A T genes Review RNA Viruses as Tools in Gene Therapy and Vaccine Development Kenneth Lundstrom PanTherapeutics, Rte de Lavaux 49, CH1095 Lutry, Switzerland; [email protected]; Tel.: +41-79-776-6351 Received: 31 January 2019; Accepted: 21 February 2019; Published: 1 March 2019 Abstract: RNA viruses have been subjected to substantial engineering efforts to support gene therapy applications and vaccine development. Typically, retroviruses, lentiviruses, alphaviruses, flaviviruses rhabdoviruses, measles viruses, Newcastle disease viruses, and picornaviruses have been employed as expression vectors for treatment of various diseases including different types of cancers, hemophilia, and infectious diseases. Moreover, vaccination with viral vectors has evaluated immunogenicity against infectious agents and protection against challenges with pathogenic organisms. Several preclinical studies in animal models have confirmed both immune responses and protection against lethal challenges. Similarly, administration of RNA viral vectors in animals implanted with tumor xenografts resulted in tumor regression and prolonged survival, and in some cases complete tumor clearance. Based on preclinical results, clinical trials have been conducted to establish the safety of RNA virus delivery. Moreover, stem cell-based lentiviral therapy provided life-long production of factor VIII potentially generating a cure for hemophilia A. Several clinical trials on cancer patients have generated anti-tumor activity, prolonged survival, and -
Module1: General Concepts
NPTEL – Biotechnology – General Virology Module1: General Concepts Lecture 1: Virus history The history of virology goes back to the late 19th century, when German anatomist Dr Jacob Henle (discoverer of Henle’s loop) hypothesized the existence of infectious agent that were too small to be observed under light microscope. This idea fails to be accepted by the present scientific community in the absence of any direct evidence. At the same time three landmark discoveries came together that formed the founding stone of what we call today as medical science. The first discovery came from Louis Pasture (1822-1895) who gave the spontaneous generation theory from his famous swan-neck flask experiment. The second discovery came from Robert Koch (1843-1910), a student of Jacob Henle, who showed for first time that the anthrax and tuberculosis is caused by a bacillus, and finally Joseph Lister (1827-1912) gave the concept of sterility during the surgery and isolation of new organism. The history of viruses and the field of virology are broadly divided into three phases, namely discovery, early and modern. The discovery phase (1886-1913) In 1879, Adolf Mayer, a German scientist first observed the dark and light spot on infected leaves of tobacco plant and named it tobacco mosaic disease. Although he failed to describe the disease, he showed the infectious nature of the disease after inoculating the juice extract of diseased plant to a healthy one. The next step was taken by a Russian scientist Dimitri Ivanovsky in 1890, who demonstrated that sap of the leaves infected with tobacco mosaic disease retains its infectious property even after its filtration through a Chamberland filter. -
Transport of Viral Specimens F
CLINICAL MICROBIOLOGY REVIEWS, Apr. 1990, p. 120-131 Vol. 3, No. 2 0893-8512/90/020120-12$02.00/0 Copyright C) 1990, American Society for Microbiology Transport of Viral Specimens F. BRENT JOHNSON Department of Microbiology, Brigham Young University, Provo, Utah 84602 INTRODUCTION .......................................................................... 120 TRANSPORT SYSTEMS.......................................................................... 120 Swabs ........................................................................... 121 Swab-Tube Combinations ........................................................................... 121 Liquid Media .......................................................................... 122 Cell culture medium .......................................................................... 122 BSS and charcoal .......................................................................... 122 Broth-based media ........................................................................... 124 Bentonite-containing media .......................................................................... 124 Buffered sorbitol and sucrose-based solutions ........................................................................ 124 Transporters .......................................................................... 125 Viruses Adsorbed onto Filters .......................................................................... 125 Virus Stability in Transport Media: a Comparison ...................................................................